The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet

Heart and Vessels

Volumn 25, Issue 6, 2010, Pages 549-555

  Aritomi, Shizuka ^a   Koganei, Hajime ^a   Wagatsuma, Hirotaka ^a   Mitsui, Akira ^a   Ogawa, Tetsuya ^b   Nitta, Kosaku ^b   Konda, Tomoyuki ^a  

^a AJINOMOTO CO INC   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin II receptor blocker; Cilnidipine; Combination therapy; Glomerular sclerosis; Hypertension

Indexed keywords

ALBUMIN; AMLODIPINE; ANGIOTENSIN II; CILNIDIPINE; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GLOMERULOSCLEROSIS; HIGH SODIUM INTAKE; KIDNEY FUNCTION; KIDNEY INJURY; MONOTHERAPY; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

ALBUMINURIA; AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, N-TYPE; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; GLOMERULONEPHRITIS; HYPERTENSION; KIDNEY; KIDNEY DISEASES; MALE; ORGAN SIZE; RATS; RATS, INBRED DAHL; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE, DIETARY; TETRAZOLES; TIME FACTORS; VALINE;

EID: 78549264398     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-010-0005-4     Document Type: Article

References (31)

1. Japanese Society of Hypertension 2006 Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004) Hypertens Res 29 Suppl S1 S105 10.1291/hypres.29.S1
2. AH Gradman 2004 Managing high-risk patients with hypertension: focus on the renin-angiotensin system J Clin Hypertens (Greenwich) 6 501 508 1:CAS:528:DC%2BD2cXotlSrsLw%3D 10.1111/j.1524-6175.2004.03524.x
3. WC Cushman CE Ford PT Einhorn JT Wright Jr RA Preston BR Davis JN Basile PK Whelton RJ Weiss A Bastien DL Courtney BP Hamilton K Kirchner GT Louis TM Retta DG Vidt ALLHAT Collaborative Research Group 2008 Blood pressure control by drug group in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) J Clin Hypertens (Greenwich) 10 751 760 1:CAS:528:DC%2BD1cXhsVOgu7bP 10.1111/j.1751-7176.2008.00015.x
4. T Konda A Enomoto J Matsushita A Takahara T Moriyama 2005 The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome Nephron Physiol 101 1 13 10.1159/000085713 (Pubitemid 41159949)
5. K Omae T Ogawa K Nitta 2009 Influence of T-calcium channel blocker treatment on deterioration of renal function in chronic kidney disease Heart Vessels 24 301 307 10.1007/s00380-008-1125-y 19626404
6. A Takahara H Koganei T Takeda S Iwata 2002 Antisympathetic and hemodynamic property of a dual L/N-type Ca(2+) channel blocker cilnidipine in rats Eur J Pharmacol 434 43 47 1:CAS:528:DC%2BD38XisVWn 10.1016/S0014-2999(01) 01521-7 11755164 (Pubitemid 34033744)
7. T Shiga Y Yamada N Matsuda T Tanaka A Urae M Hashiguchi N Hagiwara H Kasanuki 2007 Influence of cilnidipine or nisoldipine on sympathetic activity in healthy male subjects Heart Vessels 22 404 409 10.1007/s00380-007-0984-y 18043999 (Pubitemid 350201437)
8. S Nagahama T Norimatsu T Maki M Yasuda S Tanaka 2007 The effect of combination therapy with an L/N-Type Ca(2+) channel blocker, cilnidipine, and an angiotensin II receptor blocker on the blood pressure and heart rate in Japanese hypertensive patients: an observational study conducted in Japan Hypertens Res 30 815 822 1:CAS:528:DC%2BD2sXhsVyjtrrL 10.1291/hypres.30.815 18037774 (Pubitemid 47578243)
9. J Varagic D Susic ED Frohlich 2002 Cilnidipine improves spontaneously hypertensive rat coronary hemodynamics without altering cardiovascular mass and collagen J Hypertens 20 317 322 1:CAS:528:DC%2BD38XmvFCnsbk%3D 10.1097/00004872-200202000-00023 11821718 (Pubitemid 34913798)
10. K Sakata H Yoshida H Tamekiyo K Obayashi R Nawada O Doi N Mori 2003 Comparative effect of cilnidipine and quinapril on left ventricular mass in mild essential hypertension Drugs Exp Clin Res 29 117 123 1:CAS:528: DC%2BD2cXhvFCrtQ%3D%3D 14708457
11. K Takemori H Ishida K Dote K Yamamoto H Ito 2005 Prophylactic effects of an N- and L-type Ca2+ antagonist, cilnidipine, against cardiac hypertrophy and dysfunction in stroke-prone, spontaneously hypertensive rats Can J Physiol Pharmacol 83 785 790 1:CAS:528:DC%2BD2MXht12ntLfI 10.1139/y05-067 16333380 (Pubitemid 41784017)
12. H Nagai S Minatoguchi XH Chen N Wang M Arai Y Uno C Lu Y Misao H Onogi H Kobayashi G Takemura R Maruyama T Fujiwara H Fujiwara 2005 Cilnidipine, an N + L-type dihydropyridine Ca channel blocker, suppresses the occurrence of ischemia/reperfusion arrhythmia in a rabbit model of myocardial infarction Hypertens Res 28 361 368 1:CAS:528:DC%2BD2MXnsVChtb4%3D 10.1291/hypres.28.361 16138567 (Pubitemid 40895059)
13. T Tsuchihashi M Ueno M Tominaga T Kajioka U Onaka K Eto K Goto 2005 Anti-proteinuric effect of an N-type calcium channel blocker, cilnidipine Clin Exp Hypertens 27 583 591 1:CAS:528:DC%2BD2MXht1eltLrM 10.1080/10641960500298558 16303635 (Pubitemid 41722065)
14. S Kojima M Shida H Yokoyama 2004 Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases Hypertens Res 27 379 385 1:CAS:528:DC%2BD2cXntVagtLw%3D 10.1291/hypres.27.379 15253102 (Pubitemid 38996928)
15. GW Rose Y Kanno H Ikebukuro M Kaneko K Kaneko T Kanno Y Ishida H Suzuki 2001 Cilnidipine is as effective as benazepril for control of blood pressure and proteinuria in hypertensive patients with benign nephrosclerosis Hypertens Res 24 377 383 1:CAS:528:DC%2BD3MXmslWnsrc%3D 10.1291/hypres.24.377 11510750 (Pubitemid 32791814)
16. T Fujita K Ando H Nishimura T Ideura G Yasuda M Isshiki K Takahashi Cilnidipine versus Amlodipine Randomised Trial for Evaluation in Renal Disease (CARTER) Study Investigators 2007 Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease Kidney Int 72 1543 1549 1:CAS:528: DC%2BD2sXhtlKltLrJ 10.1038/sj.ki.5002623 17943080 (Pubitemid 350199443)
17. Yagi S, Goto S, Yamamoto T, Kurihara S, Katayama S (2003) Effect of cilnidipine on insulin sensitivity in patients with essential hypertension. Hypertens Res 26:383-387
18. K Yao H Sato Y Ina K Suzuki T Ohno S Shirakura 2003 Renoprotective effects of benidipine in combination with angiotensin II type 1 receptor blocker in hypertensive Dahl rats Hypertens Res 26 635 641 1:CAS:528: DC%2BD3sXovFWitL4%3D 10.1291/hypres.26.635 14567503 (Pubitemid 37086636)
19. LM Lopez AD Thorman JL Mehta 1990 Effects of amlodipine on blood pressure, heart rate, catecholamines, lipids and responses to adrenergic stimulus Am J Cardiol 66 1269 1271 1:STN:280:DyaK3M%2FltFarsw%3D%3D 10.1016/0002-9149(90)91118-P 2146871
20. JK Phillips 2005 Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents Clin Exp Pharmacol Physiol 32 415 418 1:CAS:528:DC%2BD2MXksFGrt7s%3D 10.1111/j.1440-1681.2005.04204.x 15854151 (Pubitemid 40780268)
21. M Tuncel R Augustyniak W Zhang RD Toto RG Victor 2002 Sympathetic nervous system function in renal hypertension Curr Hypertens Rep 4 229 236 10.1007/s11906-002-0012-7 12003706
22. K Eguchi K Kario K Shimada 2002 Differential effects of a long-acting angiotensin converting enzyme inhibitor (temocapril) and a long-acting calcium antagonist (amlodipine) on ventricular ectopic beats in older hypertensive patients Hypertens Res 25 329 333 1:CAS:528:DC%2BD38XlvFWnt70%3D 10.1291/hypres.25.329 12135309 (Pubitemid 34752550)
23. M Hosono T Hiruma K Watanabe Y Hayashi H Ohnishi Y Takata H Kato 1995 Inhibitory effect of cilnidipine on pressor response to acute cold stress in spontaneously hypertensive rats Jpn J Pharmacol 69 119 125 1:CAS:528: DyaK2MXovFyrtrc%3D 10.1254/jjp.69.119 8569048
24. T Konda A Enomoto A Takahara H Yamamoto 2006 Effects of L/N-type calcium channel antagonist, cilnidipine on progressive renal injuries in Dahl salt-sensitive rats Biol Pharm Bull 29 933 937 1:CAS:528:DC%2BD28Xmt1eht7s%3D 10.1248/bpb.29.933 16651722
25. J Minami Y Kawano Y Makino H Matsuoka S Takishita 2000 Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension Br J Clin Pharmacol 50 615 620 1:CAS:528:DC%2BD3MXkvV2jsA%3D%3D 10.1046/j.1365-2125.2000.00299.x 11136301 (Pubitemid 32010021)
26. S Hoshide K Kario J Ishikawa K Eguchi K Shimada 2005 Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure Hypertens Res 28 1003 1008 1:CAS:528:DC%2BD28XivVWhsbc%3D 10.1291/hypres.28.1003 16671340
27. J de Champlain M Karas L Assouline R Nadeau AR LeBlanc B Dube P Larochelle 2007 Effects of valsartan or amlodipine alone or in combination on plasma catecholamine levels at rest and during standing in hypertensive patients J Clin Hypertens (Greenwich) 9 168 178 10.1111/j.1524-6175.2007.05938.x
28. EM Seymour RV Parikh AA Singer SF Bolling 2006 Moderate calorie restriction improves cardiac remodeling and diastolic dysfunction in the Dahl-SS rat J Mol Cell Cardiol 41 661 668 1:CAS:528:DC%2BD28Xps1OksLk%3D 10.1016/j.yjmcc.2006.07.012 16934290 (Pubitemid 44376792)
29. LD Libera G Vescovo 2004 Muscle wastage in chronic heart failure, between apoptosis, catabolism and altered anabolism: a chimaeric view of inflammation? Curr Opin Clin Nutr Metab Care 7 435 441 10.1097/01.mco.0000134374.24181.5b 15192447 (Pubitemid 40340651)
30. AA Elmarakby JE Quigley DM Pollock JD Imig 2006 Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension Hypertension 47 557 562 1:CAS:528:DC%2BD28XhsFKlu7g%3D 10.1161/01.HYP.0000198545.01860.90 16415373 (Pubitemid 43843875)
31. Russell ST, Wyke SM, Tisdale MJ (2006) Mechanism of induction of muscle protein degradation by angiotensin II. Cell Signal 18(7):1087-1096